Technology | October 14, 2014

FDA Clears Kubtec’s Breast Specimen Tomosynthesis System

The new system provides shorter surgeries using less anesthesia

October 14, 2014 ­– Kubtec, a developer of digital specimen radiography systems, marks the start of Breast Cancer Awareness Month with the U.S. FDA approved, Mozart with TomoSpec, the only breast specimen radiography system with tomosynthesis technology. In providing the most comprehensive analysis of excised breast tissue in a specimen radiography system, Mozart can help reduce re-excision and patient call back rates. The speed and method with which the high resolution image slices are acquired mean shorter surgeries and less anesthesia time for the patient, lowering the risk of infection in hospitals.

 “Mozart with TomoSpec allows 3-D margin assessment in one step, without turning and repositioning the specimen container,” said Kubtec President Vikram Butani. “The system captures an entire data set in less time than it takes to acquire multiple 2-D images. This is critical for delivering a higher level of care to women undergoing surgery for breast cancer.”

Mozart with TomoSpec is a mobile system that can be located in radiology, pathology or surgery. Images can be viewed in seconds with wireless transmission to PACS or directly on the system’s monitor.

“Mozart with TomoSpec provides a quantum leap forward in intraoperative specimen radiography, elevating the standard of care,” said Chester Lowe, Ph.D., FACR, director of research and development at Kubtec.

The system offers risk reduction, enhanced throughput, superior imaging capability, increased efficiency and ease of use for surgeons, radiologists, pathologists and healthcare facilities.

This product is available worldwide.

For more information visit: www.kubtec.com/mozart.

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
Breast Cancer Places Greater Financial Burden on Black Women
News | Women's Health | May 16, 2018
Having breast cancer placed a significantly greater financial strain on black women than white women, according to a...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Overlay Init